Trial intelligence / Profile preview

[18F]FES PET/CT for ER Status in Recurrent/Metastatic Breast Cancer

NCT01986569Phase 3Completed

Sponsor
Asan Medical Center
Start
Nov 2013
Primary completion
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of fluoroestradiol f 18 in breast cancer, sponsored by Asan Medical Center. Started Nov 2013; status: completed.

02

Drugs

fluoroestradiol f 18
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01986569.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01986569.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call